Altaf Mohammed, Ph.D.
Email: altaf.mohammed@nih.gov
Phone: 240-276-6082
Room: 5E554
Biography
Altaf Mohammed, Ph.D., serves as a Program Director and Contractor Officer’s Representative (COR) in the Chemopreventive Agent Development Research Group (CADRG), Division of Cancer Prevention (DCP), National Cancer Institute (NCI). Dr. Mohammed joined DCP in January 2017.
Dr. Mohammed brings more than 16 years of experience in cancer prevention and interception, animal models, drug discovery and development and immunoprevention to his current position where he oversees and manages grants and contracts in these areas. He also led the establishment of two of NCI’s new research programs:
- Discovery and Development of Natural Products for Cancer Interception and Prevention (DDNP-CIP)
- Cancer Immunoprevention Network (CIP-Net).
Dr. Mohammed provides scientific and programmatic leadership to these newly established DDNP-CIP and CIP-Net programs.
Dr. Mohammed earned his Ph.D. in microbiology before moving to the Department of Medicine at the University of Oklahoma Health Sciences Center (OUHSC) in Oklahoma City for a postdoctoral fellowship in carcinogenesis and cancer chemoprevention. Dr. Mohammed advanced to a faculty position and pursued research in cancer chemoprevention at OUHSC. He also served as Experimental Bioassay Director at the Center for Cancer Prevention and Drug Development, Stephenson Cancer Center, at OUHSC for 8 years. At the OUHSC, Dr. Mohammed’s research interests have focused on identifying molecular targets for pancreas and colon cancers; developing effective chemopreventive/immunomodulatory agents and their regimens for preventing cancers using preclinical in vivo (carcinogen-induced, genetically engineered, and transgenic) rodent models; establishing molecular mechanisms; and identifying strategies for cancer prevention. Dr. Mohammed is one of the first investigators to optimize a genetically engineered mouse model (GEMM) for pancreatic cancer chemoprevention research.
Dr. Mohammed has published more than 90 articles in peer-reviewed journals and serves as a regular reviewer for several cancer journals, including the AACR journals. Dr. Mohammed served as a guest editor for the Current Medicinal Chemistry journal and currently serves as an Academic Editor for the PLOS One journal and Editorial Board member for the AACR Cancer Prevention Research Journal.